EUVIMEDEUVIMED entdecken
Open Access

Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking

Alexander W Thorman iD, James Reigle iD, Somchai Chutipongtanate iD, Juechen Yang, Behrouz Shamsaei iD, Marcin Pilarczyk iD, Mehdi Fazel-Najafabadi iD, Rafal Adamczak iD, Michal Kouril iD, Surbhi Bhatnagar iD, Sarah Hummel iD, Wen Niu iD und 10 weitere

Science Advances · 2024

DOI: 10.1126/sciadv.adj3010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Alexander W Thorman und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Public Health Sciences, University of Cincinnati, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Drug Discovery, Molecular Docking Simulation, Drug Repositioning. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present an in silico approach for drug discovery, dubbed connectivity enhanced structure activity relationship (ceSAR). Building on the landmark LINCS library of transcriptional signatures of drug-like molecules and gene knockdowns, ceSAR combines cheminformatic techniques with signature concordance analysis to connect small molecules and their targets and further assess their biophysical compatibility using molecular docking. Candidate compounds are first ranked in a target structure–independent manner, using chemical similarity to LINCS analogs that exhibit transcriptomic concordance with a target gene knockdown. Top candidates are subsequently rescored using docking simulations and machine learning–based consensus of the two approaches. Using extensive benchmarking, we show that ceSAR greatly reduces false-positive rates, while cutting run times by multiple orders of magnitude and further democratizing drug discovery pipelines. We further demonstrate the utility of ceSAR by identifying and experimentally validating inhibitors of BCL2A1, an important antiapoptotic target in melanoma and preterm birth–associated inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryMolecular Docking SimulationDrug RepositioningHumansTranscriptomeMachine LearningStructure-Activity Relationship

Autor:innen und Institutionen

  • Department of Environmental and Public Health Sciences, University of Cincinnati, Cincinnati, OH, USA.
  • Department of Biostatistics, Health Informatics and Data Sciences, University of Cincinnati, Cincinnati, OH, USA.
  • Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Department of Informatics, Faculty of Physics, Astronomy an Informatics, Nicolaus Copernicus University, Toruń, Poland.

ORCID-Profile: Alexander W Thorman, James Reigle, Somchai Chutipongtanate, Behrouz Shamsaei, Marcin Pilarczyk, Mehdi Fazel-Najafabadi, Rafal Adamczak, Michal Kouril, Surbhi Bhatnagar, Sarah Hummel, Wen Niu, Maria F Czyzyk-Krzeska, Robert McCullumsmith, William Seibel, Yi Zheng, David A Hildeman, Mario Medvedovic, Andrew B Herr, Jarek Meller

Förderung

  • BLRD VA
  • NCI NIH HHS
  • NCATS NIH HHS
  • NICHD NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NIEHS NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Thorman, A. W., Reigle, J., Chutipongtanate, S., Yang, J., Shamsaei, B., Pilarczyk, M., Fazel-Najafabadi, M., Adamczak, R., Kouril, M., Bhatnagar, S., Hummel, S., Niu, W., Morrow, A. L., Czyzyk-Krzeska, M. F., McCullumsmith, R., Seibel, W., Nassar, N., Zheng, Y., Hildeman, D. A., …, & Meller, J. (2024). Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking. Science Advances. https://doi.org/10.1126/sciadv.adj3010

Vancouver

Thorman AW, Reigle J, Chutipongtanate S, Yang J, Shamsaei B, Pilarczyk M, et al. Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking. Science Advances. 2024. doi:10.1126/sciadv.adj3010

BibTeX
@article{Thorman2024,
  author = {Thorman, Alexander W and Reigle, James and Chutipongtanate, Somchai and Yang, Juechen and Shamsaei, Behrouz and Pilarczyk, Marcin and Fazel-Najafabadi, Mehdi and Adamczak, Rafal and Kouril, Michal and Bhatnagar, Surbhi and Hummel, Sarah and Niu, Wen and Morrow, Ardythe L and Czyzyk-Krzeska, Maria F and McCullumsmith, Robert and Seibel, William and Nassar, Nicolas and Zheng, Yi and Hildeman, David A and Medvedovic, Mario and Herr, Andrew B and Meller, Jarek},
  title = {Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adj3010}
}
Kostenlos starten →